1. Home
  2. DARE vs COCH Comparison

DARE vs COCH Comparison

Compare DARE & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DARE
  • COCH
  • Stock Information
  • Founded
  • DARE N/A
  • COCH 1995
  • Country
  • DARE United States
  • COCH United States
  • Employees
  • DARE N/A
  • COCH N/A
  • Industry
  • DARE Biotechnology: Pharmaceutical Preparations
  • COCH Blank Checks
  • Sector
  • DARE Health Care
  • COCH Finance
  • Exchange
  • DARE Nasdaq
  • COCH Nasdaq
  • Market Cap
  • DARE 31.9M
  • COCH 29.8M
  • IPO Year
  • DARE N/A
  • COCH N/A
  • Fundamental
  • Price
  • DARE $3.34
  • COCH $1.41
  • Analyst Decision
  • DARE Strong Buy
  • COCH Strong Buy
  • Analyst Count
  • DARE 4
  • COCH 3
  • Target Price
  • DARE $20.33
  • COCH $8.00
  • AVG Volume (30 Days)
  • DARE 37.5K
  • COCH 54.8K
  • Earning Date
  • DARE 11-14-2024
  • COCH 11-14-2024
  • Dividend Yield
  • DARE N/A
  • COCH N/A
  • EPS Growth
  • DARE N/A
  • COCH N/A
  • EPS
  • DARE N/A
  • COCH N/A
  • Revenue
  • DARE $1,881,316.00
  • COCH $278,000.00
  • Revenue This Year
  • DARE N/A
  • COCH N/A
  • Revenue Next Year
  • DARE $136.52
  • COCH $19.76
  • P/E Ratio
  • DARE N/A
  • COCH N/A
  • Revenue Growth
  • DARE 88.13
  • COCH 15.35
  • 52 Week Low
  • DARE $2.67
  • COCH $1.08
  • 52 Week High
  • DARE $7.56
  • COCH $11.46
  • Technical
  • Relative Strength Index (RSI)
  • DARE 52.30
  • COCH 38.92
  • Support Level
  • DARE $3.03
  • COCH $1.21
  • Resistance Level
  • DARE $3.38
  • COCH $1.50
  • Average True Range (ATR)
  • DARE 0.12
  • COCH 0.20
  • MACD
  • DARE 0.02
  • COCH 0.01
  • Stochastic Oscillator
  • DARE 88.57
  • COCH 32.26

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

About COCH Envoy Medical Inc.

Envoy Medical Inc is a hearing health company focused on providing innovative medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life.

Share on Social Networks: